- Home
- DSGN
DSGN
Design Therapeutics Inc.
as 04-18-2025 1:35pm EST
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | CARLSBAD |
| Market Cap: | N/A | IPO Year: | 2021 |
| Target Price: | $8.00 | AVG Volume (30 days): | 143.7K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.88 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.60 - $7.77 | Next Earning Date: | 05-07-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Design Therapeutics Inc. News
DSGN Breaking Stock News: Dive into DSGN Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
April 2025's Promising Penny Stocks
MT Newswires
2 days ago
Design Therapeutics Names Chris Storgard as Chief Medical Officer
GlobeNewswire
2 days ago
Design Therapeutics Appoints Veteran Industry Executive Chris Storgard, M.D., as Chief Medical Officer
GlobeNewswire
2 days ago
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
Zacks
a month ago
Design Therapeutics (DSGN) Upgraded to Buy: Here's Why
GlobeNewswire
a month ago
Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
2 months ago
Design Therapeutics to Participate in Leerink’s Global Healthcare Conference
Simply Wall St.
2 months ago
US Penny Stocks To Watch In February 2025
Compare DSGN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DSGN Design Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.